(Q36749294)

16 August 2017

1 reference

title

Treatment of CNS dissemination in systemic lymphoma (English)

1 reference

16 August 2017

Gleissner B

1

1 reference

16 August 2017

Chamberlain M

series ordinal

2

1 reference

16 August 2017

publication date

28 February 2007

1 reference

Journal of Neuro-Oncology

16 August 2017

published in

1 reference

16 August 2017

volume

84

1 reference

16 August 2017

issue

1

1 reference

16 August 2017

page(s)

107-117

1 reference

Central nervous system relapse in non-Hodgkin lymphoma. A single-center study of 532 patients.

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11060-007-9353-Z

Meningeal localization in a patient with Hodgkin's disease. Description of a case and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-007-9353-Z

Malignant cells in cerebrospinal fluid (CSF): The meaning of a positive CSF cytology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-007-9353-Z

CSF evaluation in primary CNS lymphoma patients by PCR of the CDR III IgH genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-007-9353-Z

Isolated central nervous system relapse in aggressive non-Hodgkin's lymphoma: the Bologna experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-007-9353-Z

Incidence and risk factors of central nervous system recurrence in aggressive lymphoma--a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).

21 January 2018

1 reference

12 December 2020

CSF drug levels for children with acute lymphoblastic leukemia treated by 5 g/m2 methotrexate. A study from the EORTC Children's Leukemia Cooperative Group

1 reference

12 December 2020

Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the International Extranodal Lymphoma Study Group

1 reference

12 December 2020

Incidence and risk factors of central nervous system relapse in histologically aggressive non-Hodgkin's lymphoma uniformly treated and receiving intrathecal central nervous system prophylaxis: a GELA study on 974 patients. Groupe d'Etudes des Lympho

1 reference

12 December 2020

High-dose therapy and blood or marrow transplantation for non-Hodgkin lymphoma with central nervous system involvement

1 reference

12 December 2020

Prophylactic intrathecal methotrexate and hydrocortisone reduces central nervous system recurrence and improves survival in aggressive non-hodgkin lymphoma

1 reference

12 December 2020

Central nervous system-directed preventative therapy in adults with lymphoma

1 reference

12 December 2020

Improved prognosis of diffuse histiocytic and undifferentiated lymphoma by use of high dose methotrexate alternating with standard agents (M-BACOD)

1 reference

12 December 2020

Central nervous system prophylaxis with combined intravenous and intrathecal methotrexate in diffuse lymphoma of aggressive histologic type

1 reference

12 December 2020

Multivesicular liposomes containing 1-beta-D-arabinofuranosylcytosine for slow-release intrathecal therapy

1 reference

12 December 2020

High incidence of occult leptomeningeal disease detected by flow cytometry in newly diagnosed aggressive B-cell lymphomas at risk for central nervous system involvement: the role of flow cytometry versus cytology

1 reference

12 December 2020

Retrospective study of prognostic factors in non-Hodgkin lymphoma secondarily involving the central nervous system

1 reference

12 December 2020

Diagnosing lymphoproliferative disorders involving the cerebrospinal fluid: increased sensitivity using flow cytometric analysis

1 reference

12 December 2020

Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. Eastern Cooperative Oncology Group

1 reference

12 December 2020

Meningeal involvement in non-Hodgkin's lymphoma: symptoms, incidence, risk factors and treatment

1 reference

12 December 2020

Cerebrospinal fluid drug levels of leukemic children receiving intravenous 5 g/m2 methotrexate

1 reference

12 December 2020

Effect of dose and repeat intravenous 24 hr infusions of methotrexate on cerebrospinal fluid availability in children with hematological malignancies

1 reference

12 December 2020

Methotrexate: distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections

1 reference

12 December 2020

Cerebrospinal fluid involvement in mantle cell lymphoma

1 reference

12 December 2020

CNS involvement in small noncleaved-cell lymphoma: is CNS disease per se a poor prognostic sign?

1 reference

12 December 2020

Phase II trial of intracerebrospinal fluid etoposide in the treatment of neoplastic meningitis

1 reference

12 December 2020

Testicular lymphoma is associated with a high incidence of extranodal recurrence

1 reference

12 December 2020

Involvement of the central nervous system by non-Hodgkin's lymphoma: the Southwest Oncology Group experience

1 reference

12 December 2020

Intravascular B-cell lymphoma: report of two cases with different clinical presentation but rapid central nervous system involvement

1 reference

12 December 2020

Central nervous system involvement in indolent lymphomas

1 reference

12 December 2020

High-dose therapy with hematopoietic cell transplantation for patients with central nervous system involvement by non-Hodgkin's lymphoma

1 reference

12 December 2020

Direct administration of methotrexate into the central nervous system of primates. Part 1: Distribution and degradation of methotrexate in nervous and systemic tissue after intraventricular injection

1 reference

12 December 2020

Diffuse large-cell lymphoma of the testis

1 reference

12 December 2020

High-dose intravenous methotrexate for patients with nonleukemic leptomeningeal cancer: is intrathecal chemotherapy necessary?

1 reference

12 December 2020

[Bilateral breast masses]

1 reference

12 December 2020

Systemic chemotherapy alone for patients with non-acquired immunodeficiency syndrome-related central nervous system lymphoma: a pilot study of the BOMES protocol

1 reference

12 December 2020

Central nervous system metastases from non-Hodgkin's lymphoma: treatment and prophylaxis

1 reference

12 December 2020

Central nervous system involvement following diagnosis of non-Hodgkin's lymphoma: a risk model

1 reference

12 December 2020

Intensive conventional chemotherapy (ACVBP regimen) compared with standard CHOP for poor-prognosis aggressive non-Hodgkin lymphoma.

1 reference

12 December 2020

Characteristic features of malignant lymphoma with central nervous system involvement

1 reference

12 December 2020

CNS involvement in mantle-cell lymphoma.

1 reference

12 December 2020

Prognostic factors in 140 adult patients with non-Hodgkin's lymphoma with systemic central nervous system (CNS) involvement. A single centre analysis

1 reference

12 December 2020

Randomized trial of a slow-release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis.

1 reference

12 December 2020

Autologous bone marrow transplantation for patients with non-Hodgkin's lymphoma and CNS involvement: those transplanted with active CNS disease have a poor outcome--a report by the European Bone Marrow Transplant Lymphoma Registry

1 reference

12 December 2020

Central nervous system involvement in adult T-cell leukemia/lymphoma

1 reference

12 December 2020

Incidence and risk factors for central nervous system occurrence in elderly patients with diffuse large-B-cell lymphoma: influence of rituximab.

1 reference

12 December 2020

Central nervous system involvement in American Burkitt's lymphoma

1 reference

12 December 2020

Anthracycline-based chemotherapy as primary treatment for intravascular lymphoma

1 reference

12 December 2020

Neurologic sequelae of methotrexate and ionizing radiation: a new classification

1 reference

12 December 2020

Rituximab therapy for CNS lymphomas: targeting the leptomeningeal compartment

1 reference

12 December 2020

Pharmacokinetics of intraventricular and intravenous N,N',N''-triethylenethiophosphoramide (thiotepa) in rhesus monkeys and humans.

1 reference

12 December 2020

Central nervous system involvement in non-Hodgkin's lymphoma: an analysis of 105 cases

1 reference

12 December 2020

Central nervous system relapse in malignant lymphomas: risk factors and implications for prophylaxis

1 reference

12 December 2020

Treatment of leukemia with large doses of methotrexate and folinic acid: clinical-biochemical correlates

1 reference

12 December 2020

Radiation therapy and combination of cladribine, cyclophosphamide, and prednisone as treatment of Bing-Neel syndrome: Case report and review of the literature

1 reference

12 December 2020

Central nervous system relapse in unfavourable-histology non-Hodgkin's lymphoma: is prophylaxis indicated?

1 reference

12 December 2020

Risk factors, treatment, and outcome of central nervous system recurrence in adults with intermediate-grade and immunoblastic lymphoma.

1 reference

12 December 2020

Meningeosis leukaemica in adult acute lymphoblastic leukaemia

1 reference

12 December 2020

Successful treatment of meningeal leukemia using systemic high-dose cytosine arabinoside

1 reference

12 December 2020

Identification of early recurrence of primary central nervous system tumors by [18F]fluorodeoxyglucose positron emission tomography

1 reference

12 December 2020

Testicular lymphoma--a retrospective, population-based, clinical and immunohistochemical study.

1 reference

12 December 2020

Chemotherapy with dexamethasone, high-dose cytarabine, and cisplatin for parenchymal brain lymphoma

1 reference

12 December 2020

Is central nervous system prophylaxis necessary in ocular adnexal lymphoma?

1 reference

12 December 2020

Central nervous system relapse of systemic non-Hodgkin's lymphoma: results of treatment based on high-dose methotrexate combination chemotherapy

1 reference

12 December 2020

10.1007/S11060-007-9353-Z

Identifiers

DOI

1 reference

release_ic4gputitrf2dgf5wwsp5lawsi

16 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ic4gputitrf2dgf5wwsp5lawsi

24 November 2022

mapped directly with Wikidata item

1 reference